Ttp Investments, Inc. Abb Vie Inc. Transaction History

Ttp Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $8,575 - $10,283	-62 Reduced 1.94%	3,141 $0
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $84,820 - $97,283	632 Added 24.58%	3,203 $430,000
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $27,248 - $34,642	198 Added 8.34%	2,571 $394,000
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $3,695 - $4,585	-28 Reduced 1.17%	2,373 $385,000
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $257,939 - $326,367	2,401 New	2,401 $325,000

4,095

1.28B

16.7M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ttp Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Ttp Investments, Inc. with notifications on news.